Chondroitin Sulfate Sodium — Injectable Grade
Ultra-high-purity chondroitin sulfate sodium manufactured to injectable-grade specifications with tighter endotoxin, bioburden, heavy-metal, and residual-solvent controls than nutraceutical grades. Intended for pharmaceutical applications where parenteral purity is required.
CAS Number
9007-28-7
Physical Form
Fine white crystalline powder, low particulate
Typical Assay
Meets injectable-grade monograph; endotoxin, bioburden, residual solvent controlled
Origins
Bovine / Porcine (pharma-audited supply chain)
Purpose and Key Benefits
Enables pharmaceutical applications (viscosupplementation, ophthalmic, injectable joint therapy) that nutraceutical grades cannot serve.
Applications
Injectable joint therapy, ophthalmic solutions, viscosupplementation, regulated pharmaceutical manufacturing
Certifications
NSF-GMP Registered
NSF/ANSI 173 Section 8 · FSMA and 21 CFR Part 111/117 compliant.
NSF/ANSI 173 Sec 8
ISO 9001:2015
Quality management system.
:2015 — valid to Oct 11, 2027
ISO 22000:2018
Food safety management system.
:2018 Food Safety — valid to Oct 11, 2027
ISO 14001:2015
Environmental management system.
:2015 Environmental — valid to Nov 4, 2027
ISO 45001:2018
Occupational health and safety management system.
:2018 OH&S — valid to Nov 4, 2027
FAMI-QS Certified
Specialty feed-ingredient GMP Category K.
feed-chain certification Cat K, Registration FAM-1963; renewal in process